#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3522	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2182	471.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	527	C	457	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5820	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3863	451.7	0	.	n	.	0	T695C	SNP	695	695	T	1120	1120	C	429	C,T,A	261,114,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5820	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3863	451.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2396	2396	C	521	C,A	457,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5820	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3863	451.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2470	2470	A	559	A	475	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5820	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3863	451.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3022	3022	C	571	C	488	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	11154	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1886	1774.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	27	550	folP	852	852	100.0	folP.l15.c17.ctg.1	1865	88.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1165	1167	AGC	114;113;115	A;G;C,A	101;100;102,1	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1304	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3763	103.9	1	SNP	p	S91F	1	.	.	271	273	TTC	785	787	TTC	129;128;129	T;T;C	112;113;114	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1304	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3763	103.9	1	SNP	p	D95G	1	.	.	283	285	GGC	797	799	GGC	128;128;129	G;G;C	114;112;114	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1304	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3763	103.9	1	SNP	p	G95N	0	.	.	283	285	GGC	797	799	GGC	128;128;129	G;G;C	114;112;114	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	422	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1670	75.9	1	SNP	p	G45D	1	.	.	133	135	GAC	655	657	GAC	108;108;108	G;A;C	100;98;101	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	322	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1294	74.7	0	.	n	.	0	A197.	DEL	197	197	A	738	738	A	121	A	107	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3171	103.7	1	SNP	p	D86N	0	.	.	256	258	GAC	660	662	GAC	113;114;115	G;A,C;C	97;99,1;102	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3171	103.7	1	SNP	p	S87W	0	.	.	259	261	AGT	663	665	AGT	115;115;115	A;G;T	98;101;100	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3171	103.7	1	SNP	p	S87R	0	.	.	259	261	AGT	663	665	AGT	115;115;115	A;G;T	98;101;100	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3171	103.7	1	SNP	p	S87I	0	.	.	259	261	AGT	663	665	AGT	115;115;115	A;G;T	98;101;100	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3171	103.7	1	SNP	p	S88P	0	.	.	262	264	TCC	666	668	TCC	115;115;116	T;C;C,A	99;101;99,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_M_01355c	parE.WHO_M_01355c	1	1	27	1078	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3021	106.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1737	1739	GGC	155;155;155	G;G;C	130;125;132	parE.WHO_M_01355c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1432	1434	GCA	131;133;134	G;C;A	122;119;120	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1435	1437	ATC	134;134;135	A;T;C	120;121;123	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1447	1449	GTG	136;136;136	G;T;G	121;116;117	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1447	1449	GTG	136;136;136	G;T;G	121;116;117	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1951	1953	ACC	130;130;130	A;C;C,T	115;116;115,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2005	2007	GCG	127;127;127	G,T;C,G;G	108,1;101,1;101	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2005	2007	GCG	127;127;127	G,T;C,G;G	108,1;101,1;101	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2128	2130	GGC	137;138;138	G;G;C	111;117;112	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2137	2139	GGC	138;138;138	G;G;C,G	113;116;111,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	966	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2771	104.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2155	2157	CCG	133;132;131	C,G;C;G	106,1;114;111	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1102	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3441	96.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1780	1782	CCG	117;116;117	C;C;G	103;101;103	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	520	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2143	72.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	562	564	GGC	90;91;91	G;G;C	79;78;79	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	520	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2143	72.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	744	744	C	85	C	74	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	27	656	porB1b	1041	1041	100.0	porB1b.l6.c17.ctg.1	1985	97.9	1	SNP	p	G120K	1	.	.	358	360	AAG	802	804	AAG	125;125;125	A;A;G	111;111;109	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	27	656	porB1b	1041	1041	100.0	porB1b.l6.c17.ctg.1	1985	97.9	1	SNP	p	A121D	1	.	.	361	363	GAC	805	807	GAC	124;123;122	G;A;C,A	113;110;111,1	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	27	656	porB1b	1041	1041	100.0	porB1b.l6.c17.ctg.1	1985	97.9	1	SNP	p	D121N	0	.	.	361	363	GAC	805	807	GAC	124;123;122	G;A;C,A	113;110;111,1	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2276	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5222	130.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2192	2194	AAT	127;128;130	A,C;A;T	115,1;116;118	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	348	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1303	80.0	1	SNP	p	V57M	1	.	.	169	171	ATG	645	647	ATG	151;151;150	A;T;G	128;128;126	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
